ONTOLOGY REPORT - ANNOTATIONS
Term: heparin
Accession: CHEBI:28304
browse the term
Definition: A highly sulfated linear glycosaminoglycan comprising complex patterns of uronic acid-(1->4)-D-glucosamine repeating subunits. Used as an injectable anticoagulant, it has the highest negative charge density of any known biological molecule.
Synonyms: related_synonym: (C26H40N2O36S5)n; Bemiparin; Certoparin; Cy 222; Enoxaparin; Fluxum; Heparinic acid; Parnaparin; Reviparin; Sandoparin; heparina; heparine; heparinum
alt_id: CHEBI:24501; CHEBI:5664
xref_casrn: 9005-49-6
xref: ChemIDplus:9005-49-6 "CAS Registry Number"; CiteXplore:16860191 "PubMed citation"; CiteXplore:18809206 "PubMed citation"; CiteXplore:8713797 "PubMed citation"; DrugBank:DB01109 "DrugBank"; KEGG COMPOUND:9005-49-6 "CAS Registry Number"; KEGG COMPOUND:C00374 "KEGG COMPOUND"
xref_mesh: MESH:D006493
heparin
G
Abcc1
ATP-binding cassette, subfamily C (CFTR/MRP), member 1
affects activity
ISO
10
452,239
575,705
RGD:6480464
CTD
G
Abcc1
ATP-binding cassette, subfamily C (CFTR/MRP), member 1
multiple interactions
ISO
10
452,239
575,705
RGD:6480464
CTD
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
multiple interactions
EXP
11
25,434,262
25,443,144
RGD:6480464
CTD
G
Agt
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
multiple interactions
EXP
19
54,738,556
54,750,349
RGD:6480464
CTD
G
Akt1
v-akt murine thymoma viral oncogene homolog 1
multiple interactions
EXP
6
137,640,482
137,657,552
RGD:6480464
CTD
G
Apcs
amyloid P component, serum
increases expression
ISO
13
89,112,845
89,113,641
RGD:6480464
CTD
G
Atp1b1
ATPase, Na+/K+ transporting, beta 1 polypeptide
multiple interactions
EXP
13
80,214,056
80,234,576
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
increases expression
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
increases expression
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
increases expression
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
increases expression
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
increases expression
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
C3
complement component 3
decreases expression
ISO
RGD:6480464
CTD
G
C3
complement component 3
decreases expression
ISO
RGD:6480464
CTD
G
C5
complement component 5
decreases expression
ISO
3
14,011,115
14,102,744
RGD:6480464
CTD
G
Cacna1e
calcium channel, voltage-dependent, R type, alpha 1E subunit
multiple interactions
EXP
13
69,367,254
69,683,943
RGD:6480464
CTD
G
Casp12
caspase 12
multiple interactions
ISO
8
2,082,933
2,110,511
RGD:6480464
CTD
G
Casp3
caspase 3
decreases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Cat
catalase
increases activity
ISO
3
88,654,077
88,686,212
RGD:6480464
CTD
G
Ccl11
chemokine (C-C motif) ligand 11
affects binding
ISO
10
70,279,161
70,283,762
RGD:6480464
CTD
G
Ccl11
chemokine (C-C motif) ligand 11
multiple interactions
ISO
10
70,279,161
70,283,762
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
decreases expression
EXP
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Cd40lg
CD40 ligand
decreases expression
ISO
X
141,925,019
141,937,183
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
EXP
20
7,376,325
7,386,778
RGD:6480464
CTD
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
ISO
4
171,841,705
171,846,506
RGD:6480464
CTD
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
4
171,841,705
171,846,506
RGD:6480464
CTD
G
Col18a1
collagen, type XVIII, alpha 1
affects binding
ISO
20
11,920,816
11,982,468
RGD:6480464
CTD
G
Crp
C-reactive protein, pentraxin-related
increases expression
ISO
13
88,702,243
88,703,153
RGD:6480464
CTD
G
Csf3
colony stimulating factor 3 (granulocyte)
multiple interactions
EXP
10
87,473,990
87,476,365
RGD:6480464
CTD
G
Cxcl12
chemokine (C-X-C motif) ligand 12
decreases expression
ISO
4
153,503,576
153,516,423
RGD:6480464
CTD
G
Cxcl2
chemokine (C-X-C motif) ligand 2
multiple interactions
EXP
14
18,677,129
18,679,175
RGD:6480464
CTD
G
Cxcr4
chemokine (C-X-C motif) receptor 4
decreases expression
ISO
13
41,308,286
41,312,190
RGD:6480464
CTD
G
Cxcr7
chemokine (C-X-C motif) receptor 7
multiple interactions
EXP
9
89,343,528
89,355,053
RGD:6480464
CTD
G
Des
desmin
decreases expression
EXP
9
74,637,783
74,645,499
RGD:6480464
CTD
G
E2f1
E2F transcription factor 1
decreases expression
ISO
3
145,032,489
145,043,729
RGD:6480464
CTD
G
Edn1
endothelin 1
multiple interactions
ISO
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Edn1
endothelin 1
decreases expression
ISO
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Edn1
endothelin 1
multiple interactions
ISO
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Edn1
endothelin 1
decreases secretion
ISO
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Edn1
endothelin 1
multiple interactions
EXP
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Edn1
endothelin 1
multiple interactions
ISO
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Edn1
endothelin 1
decreases expression
ISO
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Edn1
endothelin 1
decreases secretion
ISO
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Egf
epidermal growth factor
decreases activity
ISO
2
227,103,900
227,195,062
RGD:6480464
CTD
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
14
97,617,358
97,788,211
RGD:6480464
CTD
G
Egfr
epidermal growth factor receptor
increases phosphorylation
ISO
14
97,617,358
97,788,211
RGD:6480464
CTD
G
Egln3
EGL nine homolog 3 (C. elegans)
multiple interactions
EXP
6
74,451,038
74,476,506
RGD:6480464
CTD
G
F10
coagulation factor X
decreases activity
ISO
16
81,327,237
81,346,544
RGD:6480464
CTD
G
F10
coagulation factor X
decreases activity
EXP
16
81,327,237
81,346,544
RGD:6480464
CTD
G
F2
coagulation factor II
multiple interactions
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2
coagulation factor II
multiple interactions
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2
coagulation factor II
increases expression
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2
coagulation factor II
multiple interactions
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2
coagulation factor II
multiple interactions
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2
coagulation factor II
multiple interactions
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2
coagulation factor II
multiple interactions
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2
coagulation factor II
decreases expression
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2
coagulation factor II
increases expression
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2
coagulation factor II
multiple interactions
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2
coagulation factor II
multiple interactions
ISO
3
76,005,318
76,018,603
RGD:6480464
CTD
G
F2r
coagulation factor II (thrombin) receptor
multiple interactions
ISO
2
25,985,800
25,989,072
RGD:6480464
CTD
G
Fas
Fas (TNF receptor superfamily, member 6)
increases expression
ISO
1
238,259,443
238,274,745
RGD:6480464
CTD
G
Fcgr2a
Fc fragment of IgG, low affinity IIa, receptor
affects binding
ISO
13
86,898,651
86,911,743
RGD:6480464
CTD
G
Fga
fibrinogen alpha chain
increases cleavage
ISO
2
174,737,640
174,753,598
RGD:6480464
CTD
G
Fgf1
fibroblast growth factor 1 (acidic)
multiple interactions
ISO
18
31,785,480
31,806,452
RGD:6480464
CTD
G
Fgf1
fibroblast growth factor 1 (acidic)
multiple interactions
ISO
18
31,785,480
31,806,452
RGD:6480464
CTD
G
Fgf1
fibroblast growth factor 1 (acidic)
multiple interactions
EXP
18
31,785,480
31,806,452
RGD:6480464
CTD
G
Fgf1
fibroblast growth factor 1 (acidic)
affects binding
EXP
18
31,785,480
31,806,452
RGD:6480464
CTD
G
Fgf1
fibroblast growth factor 1 (acidic)
multiple interactions
EXP
18
31,785,480
31,806,452
RGD:6480464
CTD
G
Fgf1
fibroblast growth factor 1 (acidic)
multiple interactions
EXP
18
31,785,480
31,806,452
RGD:6480464
CTD
G
Fgf10
fibroblast growth factor 10
multiple interactions
ISO
2
50,866,799
50,940,319
RGD:6480464
CTD
G
Fgf19
fibroblast growth factor 19
affects binding
ISO
1
205,324,890
205,328,178
RGD:6480464
CTD
G
Fgf19
fibroblast growth factor 19
multiple interactions
ISO
1
205,324,890
205,328,178
RGD:6480464
CTD
G
Fgf2
fibroblast growth factor 2
affects binding
ISO
2
123,893,314
123,947,136
RGD:6480464
CTD
G
Fgf2
fibroblast growth factor 2
affects binding
ISO
2
123,893,314
123,947,136
RGD:6480464
CTD
G
Fgf2
fibroblast growth factor 2
multiple interactions
ISO
2
123,893,314
123,947,136
RGD:6480464
CTD
G
Fgf2
fibroblast growth factor 2
multiple interactions
ISO
2
123,893,314
123,947,136
RGD:6480464
CTD
G
Fgf2
fibroblast growth factor 2
affects activity
EXP
2
123,893,314
123,947,136
RGD:6480464
CTD
G
Fgf2
fibroblast growth factor 2
multiple interactions
EXP
2
123,893,314
123,947,136
RGD:6480464
CTD
G
Fgf2
fibroblast growth factor 2
affects binding
EXP
2
123,893,314
123,947,136
RGD:6480464
CTD
G
Fgf2
fibroblast growth factor 2
multiple interactions
EXP
2
123,893,314
123,947,136
RGD:6480464
CTD
G
Fgf2
fibroblast growth factor 2
decreases expression
EXP
2
123,893,314
123,947,136
RGD:6480464
CTD
G
Fgf23
fibroblast growth factor 23
increases activity
ISO
4
163,468,604
163,476,325
RGD:6480464
CTD
G
Fgf3
fibroblast growth factor 3
affects activity
ISO
1
205,269,480
205,273,404
RGD:6480464
CTD
G
Fgf4
fibroblast growth factor 4
multiple interactions
ISO
1
205,292,272
205,293,705
RGD:6480464
CTD
G
Fgf5
fibroblast growth factor 5
affects activity
ISO
14
12,713,971
12,734,634
RGD:6480464
CTD
G
Fgf7
fibroblast growth factor 7
affects binding
EXP
3
113,468,427
113,517,538
RGD:6480464
CTD
G
Fgfr1
Fibroblast growth factor receptor 1
affects binding
ISO
16
70,869,974
70,910,045
RGD:6480464
CTD
G
Fgfr1
Fibroblast growth factor receptor 1
multiple interactions
ISO
16
70,869,974
70,910,045
RGD:6480464
CTD
G
Fgfr2
fibroblast growth factor receptor 2
multiple interactions
ISO
1
189,482,975
189,589,279
RGD:6480464
CTD
G
Fgfr2
fibroblast growth factor receptor 2
multiple interactions
ISO
1
189,482,975
189,589,279
RGD:6480464
CTD
G
Fgfr2
fibroblast growth factor receptor 2
affects activity
ISO
1
189,482,975
189,589,279
RGD:6480464
CTD
G
Fgfr2
fibroblast growth factor receptor 2
multiple interactions
ISO
1
189,482,975
189,589,279
RGD:6480464
CTD
G
Fgfr2
fibroblast growth factor receptor 2
affects binding
EXP
1
189,482,975
189,589,279
RGD:6480464
CTD
G
Fgfr3
fibroblast growth factor receptor 3
affects activity
ISO
14
82,683,191
82,697,229
RGD:6480464
CTD
G
Fgfr3
fibroblast growth factor receptor 3
multiple interactions
ISO
14
82,683,191
82,697,229
RGD:6480464
CTD
G
Fgfr4
fibroblast growth factor receptor 4
affects binding
ISO
17
15,512,144
15,527,348
RGD:6480464
CTD
G
Fgfr4
fibroblast growth factor receptor 4
multiple interactions
ISO
17
15,512,144
15,527,348
RGD:6480464
CTD
G
Fgfr4
fibroblast growth factor receptor 4
multiple interactions
EXP
17
15,512,144
15,527,348
RGD:6480464
CTD
G
Fgfr4
fibroblast growth factor receptor 4
multiple interactions
ISO
17
15,512,144
15,527,348
RGD:6480464
CTD
G
Fos
FBJ osteosarcoma oncogene
increases expression
ISO
6
109,559,135
109,562,001
RGD:6480464
CTD
G
Fos
FBJ osteosarcoma oncogene
multiple interactions
EXP
6
109,559,135
109,562,001
RGD:6480464
CTD
G
Fos
FBJ osteosarcoma oncogene
decreases expression
EXP
6
109,559,135
109,562,001
RGD:6480464
CTD
G
Gata4
GATA binding protein 4
multiple interactions
EXP
15
42,472,793
42,519,569
RGD:6480464
CTD
G
Gns
glucosamine (N-acetyl)-6-sulfatase
affects degradation
ISO
7
60,672,492
60,702,306
RGD:6480464
CTD
G
Gzmb
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
multiple interactions
EXP
15
35,195,075
35,198,506
RGD:6480464
CTD
G
Gzmbl2
Granzyme B-like 2
multiple interactions
EXP
15
35,061,676
35,074,048
RGD:6480464
CTD
G
Hgf
hepatocyte growth factor
multiple interactions
ISO
4
14,864,357
14,932,513
RGD:6480464
CTD
G
Hgf
hepatocyte growth factor
increases expression
ISO
4
14,864,357
14,932,513
RGD:6480464
CTD
G
Hgf
hepatocyte growth factor
affects binding
ISO
4
14,864,357
14,932,513
RGD:6480464
CTD
G
Hpse
heparanase
multiple interactions
ISO
14
10,144,322
10,185,115
RGD:6480464
CTD
G
Hrg
histidine-rich glycoprotein
multiple interactions
ISO
11
80,248,578
80,264,179
RGD:6480464
CTD
G
Igsf10
immunoglobulin superfamily, member 10
multiple interactions
EXP
2
148,704,646
148,734,103
RGD:6480464
CTD
G
Il6
interleukin 6
increases expression
ISO
4
456,799
461,376
RGD:6480464
CTD
G
Il6
interleukin 6
multiple interactions
EXP
4
456,799
461,376
RGD:6480464
CTD
G
Itgam
integrin, alpha M
decreases expression
ISO
1
187,334,413
187,385,583
RGD:6480464
CTD
G
Itgam
integrin, alpha M
increases expression
ISO
1
187,334,413
187,385,583
RGD:6480464
CTD
G
Itgax
integrin, alpha X
decreases expression
ISO
1
187,396,184
187,416,273
RGD:6480464
CTD
G
Jun
jun proto-oncogene
multiple interactions
ISO
5
115,358,166
115,361,259
RGD:6480464
CTD
G
Jun
jun proto-oncogene
multiple interactions
ISO
5
115,358,166
115,361,259
RGD:6480464
CTD
G
Klf4
Kruppel-like factor 4 (gut)
multiple interactions
EXP
5
73,446,928
73,451,286
RGD:6480464
CTD
G
Krt18
keratin 18
increases expression
ISO
RGD:6480464
CTD
G
Lpl
lipoprotein lipase
multiple interactions
EXP
16
22,533,105
22,556,905
RGD:6480464
CTD
G
Map2k1
mitogen activated protein kinase kinase 1
multiple interactions
EXP
8
68,379,074
68,451,554
RGD:6480464
CTD
G
Map2k2
mitogen activated protein kinase kinase 2
multiple interactions
EXP
7
10,074,654
10,094,003
RGD:6480464
CTD
G
Mapk1
mitogen activated protein kinase 1
increases activity
ISO
11
85,968,732
86,030,387
RGD:6480464
CTD
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP
11
85,968,732
86,030,387
RGD:6480464
CTD
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
11
85,968,732
86,030,387
RGD:6480464
CTD
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
11
85,968,732
86,030,387
RGD:6480464
CTD
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
1
185,935,044
185,941,245
RGD:6480464
CTD
G
Mapk3
mitogen activated protein kinase 3
increases activity
ISO
1
185,935,044
185,941,245
RGD:6480464
CTD
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP
1
185,935,044
185,941,245
RGD:6480464
CTD
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
1
185,935,044
185,941,245
RGD:6480464
CTD
G
Mapt
microtubule-associated protein tau
multiple interactions
ISO
10
93,411,098
93,508,762
RGD:6480464
CTD
G
Mmp1
matrix metallopeptidase 1 (interstitial collagenase)
decreases activity
ISO
8
4,333,773
4,354,284
RGD:6480464
CTD
G
Mmp2
matrix metallopeptidase 2
decreases activity
ISO
19
15,246,036
15,275,061
RGD:6480464
CTD
G
Mmp9
matrix metallopeptidase 9
decreases activity
ISO
3
155,985,473
155,993,433
RGD:6480464
CTD
G
Mmp9
matrix metallopeptidase 9
increases expression
ISO
3
155,985,473
155,993,433
RGD:6480464
CTD
G
Mmp9
matrix metallopeptidase 9
increases expression
ISO
3
155,985,473
155,993,433
RGD:6480464
CTD
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
3
155,985,473
155,993,433
RGD:6480464
CTD
G
Mmp9
matrix metallopeptidase 9
increases expression
ISO
3
155,985,473
155,993,433
RGD:6480464
CTD
G
Myc
myelocytomatosis oncogene
increases expression
ISO
7
98,953,142
98,958,060
RGD:6480464
CTD
G
Myc
myelocytomatosis oncogene
decreases expression
EXP
7
98,953,142
98,958,060
RGD:6480464
CTD
G
Myc
myelocytomatosis oncogene
increases expression
ISO
7
98,953,142
98,958,060
RGD:6480464
CTD
G
Nfatc3
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
multiple interactions
EXP
19
35,907,800
35,982,095
RGD:6480464
CTD
G
Pdgfb
platelet-derived growth factor beta polypeptide
affects expression
EXP
7
118,244,385
118,262,021
RGD:6480464
CTD
G
Pf4
platelet factor 4
affects binding
ISO
14
18,812,550
18,813,259
RGD:6480464
CTD
G
Pf4
platelet factor 4
affects binding
ISO
14
18,812,550
18,813,259
RGD:6480464
CTD
G
Pf4
platelet factor 4
increases secretion
ISO
14
18,812,550
18,813,259
RGD:6480464
CTD
G
Pf4
platelet factor 4
increases secretion
ISO
14
18,812,550
18,813,259
RGD:6480464
CTD
G
Pf4
platelet factor 4
affects binding
ISO
14
18,812,550
18,813,259
RGD:6480464
CTD
G
Plat
plasminogen activator, tissue
increases expression
ISO
16
73,711,323
73,736,328
RGD:6480464
CTD
G
Plat
plasminogen activator, tissue
increases expression
ISO
16
73,711,323
73,736,328
RGD:6480464
CTD
G
Plg
plasminogen
multiple interactions
ISO
1
42,782,464
42,825,149
RGD:6480464
CTD
G
Potef
POTE ankyrin domain family, member F
multiple interactions
EXP
18
24,420,779
24,422,284
RGD:6480464
CTD
G
Ppbp
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
increases secretion
ISO
14
18,816,434
18,817,238
RGD:6480464
CTD
G
Proc
protein C
increases activity
ISO
18
24,563,368
24,573,715
RGD:6480464
CTD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
13
64,427,288
64,432,978
RGD:6480464
CTD
G
Ptk2
protein tyrosine kinase 2
decreases phosphorylation
ISO
7
110,933,298
111,084,554
RGD:6480464
CTD
G
Pxn
paxillin
decreases phosphorylation
ISO
12
42,322,193
42,370,507
RGD:6480464
CTD
G
Rac1
ras-related C3 botulinum toxin substrate 1
multiple interactions
EXP
12
11,380,314
11,400,531
RGD:6480464
CTD
G
Rb1
retinoblastoma 1
multiple interactions
ISO
15
53,828,881
53,962,099
RGD:6480464
CTD
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
ISO
1
208,262,669
208,273,148
RGD:6480464
CTD
G
S100a1
S100 calcium binding protein A1
affects expression
EXP
2
182,784,818
182,787,370
RGD:6480464
CTD
G
S100a6
S100 calcium binding protein A6
affects expression
EXP
2
182,895,080
182,896,305
RGD:6480464
CTD
G
S100b
S100 calcium binding protein B
affects expression
EXP
20
12,791,440
12,824,508
RGD:6480464
CTD
G
Sell
selectin L
decreases expression
ISO
13
79,827,342
79,845,296
RGD:6480464
CTD
G
Sell
selectin L
increases expression
ISO
13
79,827,342
79,845,296
RGD:6480464
CTD
G
Selp
selectin P
multiple interactions
ISO
13
79,886,614
79,922,180
RGD:6480464
CTD
G
Selp
selectin P
increases expression
ISO
13
79,886,614
79,922,180
RGD:6480464
CTD
G
Serpinc1
serpin peptidase inhibitor, clade C (antithrombin), member 1
decreases expression
ISO
13
76,548,456
76,562,724
RGD:6480464
CTD
G
Serpinc1
serpin peptidase inhibitor, clade C (antithrombin), member 1
multiple interactions
ISO
13
76,548,456
76,562,724
RGD:6480464
CTD
G
Serpinc1
serpin peptidase inhibitor, clade C (antithrombin), member 1
decreases expression
ISO
13
76,548,456
76,562,724
RGD:6480464
CTD
G
Serpinc1
serpin peptidase inhibitor, clade C (antithrombin), member 1
multiple interactions
ISO
13
76,548,456
76,562,724
RGD:6480464
CTD
G
Serpine1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
multiple interactions
EXP
12
20,931,996
20,942,374
RGD:6480464
CTD
G
Slc5a3
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3
multiple interactions
EXP
11
32,063,275
32,065,721
RGD:6480464
CTD
G
Slk
STE20-like kinase
multiple interactions
EXP
1
252,954,514
253,007,330
RGD:6480464
CTD
G
Tfrc
transferrin receptor
multiple interactions
EXP
11
69,976,258
69,998,098
RGD:6480464
CTD
G
Tgfb1
transforming growth factor, beta 1
decreases expression
EXP
1
80,894,705
80,911,020
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
multiple interactions
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
increases expression
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tp53
tumor protein p53
decreases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Vegfa
vascular endothelial growth factor A
affects binding
ISO
9
10,520,730
10,536,071
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest